GEN-003

Shares of Genocea Biosciences Inc (NASDAQ: GNCA), a biopharmaceutical company that focuses on diseases with unmet needs, surged higher by more than 30 percent on Thursday. Genocea Biosciences announced earlier in the morning data from a 12-month Phase 2 study evaluating its lead candidate GEN...